Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.
Clinical heterogeneity in multiple sclerosis is the rule. Evidence suggests that HLA-DRB1*15 may play a role in clinical outcome. Spinal cord pathology is common and contributes significantly to disability in the disease. The influence of HLA-DRB1*15 on multiple sclerosis spinal cord pathology is un...
Autors principals: | DeLuca, G, Alterman, R, Martin, J, Mittal, A, Blundell, S, Bird, S, Beale, H, Hong, L, Esiri, M |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2013
|
Ítems similars
-
The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.
per: Yates, R, et al.
Publicat: (2014) -
Spinal cord neuronal pathology in multiple sclerosis.
per: Gilmore, C, et al.
Publicat: (2009) -
Comment: HLA-DRB1*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis
per: Yates, R, et al.
Publicat: (2016) -
Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions
per: Evangelou, N, et al.
Publicat: (2005) -
Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions.
per: Evangelou, N, et al.
Publicat: (2005)